hotspot -WSS

hotspot

author：leisure time 2025-10-01 01:50:59 - browse：55556

Adobe

LONDON — Merck said Wednesday it is buying ophthalmology-focused startup EyeBio in a deal worth up to $3 billion, as the pharma company looks to diversify its pipeline.

Under the deal, Merck, through a subsidiary, will pay $1.3 billion in cash upfront, with another $1.7 billion potentially included if certain regulatory and commercial milestones are met. The Wall Street Journal first reported the news Tuesday night.

EyeBio has been developing a drug called restoret for a number of retinal diseases, including age-related macular degeneration and diabetic macular edema. It presented data in February from a Phase 1/2 trial of restoret in both conditions. Merck said it plans to move restoret into a pivotal trial for diabetic macular edema later this year.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Physician executives need more than on

focus

WSS

Why ADHD is under

Threats against the LGBTQIA+ community intensifying: Department of Homeland Security

Chan Zuckerberg Biohub Chicago to focus on inflammation

Charles Manson follower Leslie Van Houten released from prison after 53 years

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

Bill would stop addiction treatment from triggering child abuse inquiry

explore

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

explore

In Memoriam: Notable people who died in 2023

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

Alkermes shareholders re

HCA discloses massive data breach affecting 11 million patients

Anesthesiologist group: stop taking Ozempic before surgery

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Continuity nursing helped my family in our darkest PICU moments

HCA discloses massive data breach affecting 11 million patients

Malaria cases in Florida and Texas: Here’s what you need to know

Beach reads and more: STAT's 2023 summer book list

hotspot

The future of health care in the House

FDA authorizes Novavax’s updated Covid

Biden launches a new push to limit health care costs

Iowa House, Senate pass 6

Sana to lay off nearly a third of staff, de

Colorectal cancer study finds potential in overlooked immune cell

hotspot

focus

entertainment

explore